CLOROX CO /DE/
S-8, 1994-11-22
SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS
Previous: CITICORP, 424B5, 1994-11-22
Next: CLOROX CO /DE/, S-8, 1994-11-22






         As filed with the Securities and Exchange
Commission on November 21, 1994.  Registration No. 33-
                                                      ------
- ------------------------------------------------------------
            SECURITIES AND EXCHANGE COMMISSION
                  Washington, D.C. 20549

                         FORM S-8

  REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933


                    THE CLOROX COMPANY
  (Exact name of registrant as specified in its charter)

         Delaware                         31-0595760
(State or other jurisdiction           (I.R.S. Employer
of incorporation or organization)      Identification No.)

1221 Broadway, Oakland, CA                  94612-1888
(Address of Principal Executive Offices)    (Zip Code)

     THE CLOROX COMPANY LONG-TERM COMPENSATION PROGRAM
                 (Full title of the plan)

          Edward A. Cutter, Senior Vice President - 
               General Counsel and Secretary
                    The Clorox Company,
           1221 Broadway, Oakland, CA 94612-1888
          (Name and address of agent for service)

                       510-271-7000
          (Telephone number, including area code,
                   of agent for service)
               ---------------------------------
              Calculation of Registration Fee
- ------------------------------------------------------------
                         Proposed  Proposed      
Title of      Number     Maximum   Maximum       Amount of
Securities    of shares  Offering  Aggregate     Regis-
to be         to be      Price Per Offering      tration
Registered    Registered Share     Price         Fee
- ------------------------------------------------------------

Common Stock  1,700,000  $56.50* $96,050,000.00  $33,120.69*
- ------------------------------------------------------------

*   Pursuant to Rule 457(c) and (h), estimate based on the 
    average high and low sale prices of Clorox common stock on
    the New York Stock Exchange on November 16, 1994.  




                          Part II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT


Item 3.  Incorporation of Documents by Reference.

         The contents of the registration statement on
Form S-8 filed by the Company on September 26, 1988 (File
No. 33-24582) are incorporated by reference herein.  


Item 4.  Description of Securities.

         Not applicable.

Item 5.  Interests of Named Experts and Counsel.

         Edward A. Cutter, Esq., who has rendered an opinion
regarding the validity of the securities being registered
hereby, is the Senior Vice President-General Counsel and
Secretary of the Company.  As of July 29, 1994, Mr. Cutter
owned 40,327 shares of the Company's common stock, including
24,558 shares issuable upon the exercise of stock options
that were exercisable within 60 days of such date.  

Item 6.  Indemnification of Directors and Officers.

         Not applicable.  

Item 7.  Exemption from Registration Claimed.

         Not applicable.  























                           II-1
Item 8.  Exhibits.

                       Exhibit Index
                       -------------

Exh. No.      Description
- -------       -----------------------------------------------
   (5)        Opinion of Edward A. Cutter, Esq., Senior Vice
              President - General Counsel and Secretary
              of the Company (located at page E-1 hereof).  

  (23)(a)     Consent of Deloitte & Touche LLP (located at 
              page E-2 hereof).

      (b)     Consent of Edward A. Cutter, Esq. (included in
              Exhibit 5 above).

  (24)        Manually executed Power of Attorney of Daniel
              Boggan, Jr., John W. Collins, Ursula
              Fairchild, Jochen Krautter, Juergen Manchot,
              Dean O. Morton, Edward L. Scarff, Lary R.
              Scott, Forrest N. Shumway, James A. Vohs and
              C.A. Wolfe, dated March 16, 1994 (located at
              page E-3 hereof).  



Item 9.  Undertakings.

         Not applicable.


























                          II-2
                        SIGNATURES

         Pursuant to the requirements of the Securities Act
of 1933, the registrant certifies that it has reasonable
grounds to believe that it meets all of the requirements for
filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Oakland, State of
California on November 21, 1994.

                             THE CLOROX COMPANY
                             
                             
                             
                             By: /s/ G. CRAIG SULLIVAN
                                 G. Craig Sullivan
                                 Chairman and 
                                 Chief Executive Officer
                             
                             
         Pursuant to the requirements of the Securities Act
of 1933, this Registration Statement has been signed by the
following persons in the capacities and on the dates
indicated.  

<TABLE>
<CAPTION>

        Signature                       Title                    Date        
- -----------------------------  ---------------------------  -----------------------
<S>                            <C>                          <C>

/s/ G. CRAIG SULLIVAN          Chairman of the Board,       November 21, 1994
    G. Craig Sullivan            Chief Executive Officer
                                 and Director (principal
                                 executive officer)


/s/ WILLIAM F. AUSFAHL         Group Vice President,        November 21, 1994
    William F. Ausfahl           Chief Financial Officer
                                 and Director (principal
                                 financial officer)


/s/ HENRY J. SALVO, JR.        Vice President-Controller    November 21, 1994
    Henry J. Salvo, Jr.          (principal accounting
                                  officer)


/s/ DANIEL BOGGAN, JR.           Director                     November 21, 1994
   * Daniel Boggan, Jr.         

</TABLE>
<PAGE>

                           II-3

<TABLE>
<CAPTION>

        Signature                       Title                    Date        
- -----------------------------  ---------------------------  -----------------------
<S>                            <C>                          <C>


/s/ JOHN W. COLLINS            Director                     November 21, 1994
    * John W. Collins


/s/ URSULA FAIRCHILD           Director                     November 21, 1994
    * Ursula Fairchild


/s/ JOCHEN KRAUTTER            Director                     November 21, 1994
    * Jochen Krautter


/s/ JUERGEN MACHOT             Director                     November 21, 1994
    * Juergen Manchot


/s/ DEAN O. MORTON             Director                     November 21, 1994
    * Dean O. Morton


/s/ EDWARD L. SCARFF           Director                     November 21, 1994
    * Edward L. Scarff


/s/ LARY R. SCOTT              Director                     November 21, 1994
    * Lary R. Scott


/s/ FORREST N. SHUMWAY         Director                     November 21, 1994
    * Forrest N. Shumway


/s/ JAMES A. VOHS              Director                     November 21, 1994
    * James A. Vohs


/s/ C. A. WOLFE                Director                     November 21, 1994
    * C. A. Wolfe

</TABLE>


* By /s/ EDWARD A. CUTTER
      Edward A. Cutter, Esq.
      (Attorney in Fact)

                                   II-4


                      EXHIBIT 5 TO
             FORM S-8 REGISTRATION STATEMENT
                       REGARDING
                   THE CLOROX COMPANY
              LONG-TERM COMPENSATION PROGRAM



November 21, 1994


Ladies and Gentlemen:

This is with respect to the Registration Statement on Form S-8, 
to which this opinion is an exhibit, covering 1,700,000 shares 
of Clorox Common Stock which may be issued pursuant to exercise
of options granted under The Clorox Company 1987 Long-Term 
Compensation Program.

It is my opinion that:

1.  All necessary corporate action has been duly taken to adopt 
said Plan and said Plan was duly approved by action of 
the stockholders of The Clorox Company.

2.  Said 1,700,000 shares of Clorox Common Stock have been 
reserved for purposes of said Plan and such shares, when 
issued on exercise of options granted in accordance with 
the terms and conditions of said Plan, will be legally issued, 
fully paid and non-assessable.

I hereby consent to the filing of this opinion with the 
Securities and Exchange Commission as an exhibit to the 
aforesaid registration statement.

Very truly,



/s/ EDWARD A. CUTTER
Edward A. Cutter
Senior Vice President -
General Counsel and
Secretary





                       E-1


                       EXHIBIT 23(a) TO
                FORM S-8 REGISTRATION STATEMENT
                          REGARDING
                     THE CLOROX COMPANY
              LONG-TERM COMPENSATION PROGRAM




INDEPENDENT AUDITORS' CONSENT


We consent to the incorporation by reference in this Registration 
Statement of The Clorox Company on Form S-8 of the reports of 
Deloitte & Touche dated August 10, 1994, appearing in and 
incorporated by reference in the Annual Report on Form 10-K 
of The Clorox Company for the year ended June 30, 1994.





/s/ DELOITTE & TOUCHE LLP

San Francisco, California
November 21, 1994







                E-2


                      EXHIBIT 24 TO 
             FORM S-8 REGISTRATION STATEMENT
                       REGARDING
                  THE CLOROX COMPANY
            LONG-TERM COMPENSATION PROGRAM 




                   POWER OF ATTORNEY

Know All Men By These Presents:

  WHEREAS, The Clorox Company, a Delaware corporation 
(the "Company"), contemplates filing with the Securities and 
Exchange Commission (the "Commission") at Washington, D.C., 
under the provisions of the Securities Act of 1933, as 
amended, and the regulations promulgated thereunder, a 
Registration Statement on Form S-8 (and amendments thereto, 
including post-effective amendments), with respect to up to 
100,000 shares of the Company's common stock to be 
purchased pursuant to the Company's 1993 Directors' Stock 
Option Plan.

  WHEREAS, each of the undersigned is an officer or director, 
or both, of the Company.

  NOW, THEREFORE, each of the undersigned hereby constitutes 
and appoints Edward A. Cutter his or her true and lawful 
attorney-in-fact and agent, with full power of substitution 
and resubstitution, for each such person and in his or her 
name, place and stead, in any and all capacities, to sign 
the aforementioned Registration Statement (and any and all 
amendments thereto, including post-effective amendments) and 
to file the same, with all exhibits thereto, and other 
documents in connection therewith, with the Commission, 
granting unto said attorney-in-fact and agent full power and 
authority to do and perform each and every act and thing 
requisite and necessary to be done, as fully as to all 
intents and purposes he or she might or could do in person, 
hereby ratifying and confirming all that said attorney-in-fact 
and agent, or their substitutes, may lawfully do and cause to 
be done by virtue hereof.

  IN WITNESS WHEREOF, each of the undersigned has hereunto set 
his or her hand on the 16th day of March, 1994.



  /s/ DANIEL BOGGAN, JR.              /s/ JOHN W. COLLINS
  Daniel Boggan, Jr.                  John W. Collins


  /s/ URSULA FAIRCHILD                /s/ JOCHEN KRAUTTER
  Ursula Fairchild                    Jochen Krautter


  /s/ JUERGEN MANCHOT                 /s/ DEAN O. MORTON
  Juergen Manchot                     Dean O. Morton


  /s/ EDWARD L. SCARFF                /s/ LARY R. SCOTT
  Edward L. Scarff                    Lary R. Scott


  /s/ FORREST N. SHUMWAY              /s/ JAMES A. VOHS
  Forrest N. Shumway                  James A. Vohs


  /s/ C. A. WOLFE
  C. A. Wolfe


                    E-3



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission